Page 1
Milan, June 11, 2015
ROLE OF FOOD – DERIVED ANTIOXIDANTS IN DERMATOLOGY AND COSMETOLOGY
Gabriella Calviello - Leonardo Celleno Institutes of General Pathology and Clinical Dermatology, and Research Center for Biotechnologies Applied to Cosmetology School of Medicine, Università Cattolica S. Cuore, Rome, Italy
Page 2
Inhibit the activity of other compounds
Instable compounds highly reactive very short half-life
• Free radicals
Oxidants
• Non free radicals
ROS RNS
Skin
ANTIOXIDANTS
Page 3
ANTIOXIDANTS Late ’80 Early ‘90
Public attention
Involved in the modulation of the pathogenesis of several chronic diseases (atherosclerosis, cancer, visual disorders, etc)
Low dietary intake of fruit and vegetables rich in antioxidants
risk of these chronic diseases
Preclinical Studies
Human Observational
Studies
Page 4
Increasing clinical experimental evidences
to demonstrate the usefulness of these antioxidant molecules
have contributed
Page 5
ANTIOXIDANT DEFENSE
Normal redox state
Exogenous sources
UVR Environmental toxins
Chemicals
Ionizing radiations
The most vulnerable organ to radiations and environmental chemicals
ROS Endogenous sources
Melanogenesis
Mitochondria
Cytochrome P450 NADPH oxidase
Lipoxygenases
Peroxisomes
Inflammation Skin
Page 6
ANTIOXIDANT DEFENSE
Exogenous sources
Normal redox state
Enzymatic: Catalase SOD, Superoxide dismutase GPX, Glutathione peroxidase
HO-1, Heme oxygenase 1 GST, Glutathione S-transferase NQO1, NAD(P)H dehydrogenase quinone 1 PRX, Peroxiredoxin
Non enzymatic: Eumelanin Ferritin Glutathione Vitamin A Vitamin C Vitamin E
ROS Endogenous
sources
Page 7
ANTIOXIDANT DEFENSE OXIDATIVE STRESS
Cellular substructures
Photoaging Immunosuppression Photocarcinogenesis
CLINICAL EFFECTS
UVR
ROS
Lipid peroxidation
Protein oxidation
DNA mutation
Page 8
Counteracting
In the prevention and treatment
A main challenge
ROS
Skin photoaging
Skin photocarcinogenesis
at skin level
Page 11
largely derived from plants and naturally contained in foods
Request for more targeted antioxidants
Page 12
These substances are now widely used in many fields of medical therapy and also in dermatology
administered topically or systemically
for inflammatory dermatosis and photodermatology
Naturally-derived compounds with antioxidant properties
Dermatology field In the search for new preventive or therapeutic strategies for chronic skin pathologies
Page 13
Natural extracts as safe source of antioxidants
Cosmetic field
Page 14
To test the potential antioxidant efficacy of natural compounds alone or in combination
Our AIM
an experimental procedure which involves the use of different in vitro and in vivo models
Page 15
The antioxidant ability of a substance is evaluated
First step
Human and mouse-derived cultured cells
a) The intracellular production of ROS
b) Cellular lipid peroxidation
Cytofluorimetric analysis using the fluorescent probe dichlorofluorescein diacetate (DCFA)
Spectrophotometrical analysis using the TBARS (thiobarbituric acid reactive substances) assay.
c) Cellular total antioxidant capacity (TAC)
Colorimetric analysis (ELISA KIT)
By measuring its ability to modulate:
in
Page 16
On the basis of the results obtained
Evaluating the ability of the substance to regulate the cellular level/expression of various endogenous antioxidants
Tot GSH CuZnSOD
HO-1 GSH
reductase
Second step
Page 17
Designing of experimental clinical trials on a significant number of people monitored during the treatment
Third step
If the outcomes are satisfactory
To verify the effectiveness of the compound in vivo
UVR
UV as a stimulus capable of producing an excess of free radicals
ROS
Page 18
• Omega-3 Normal and neoplastic human skin cell lines, animal models, humans
• Glycerophosphoinositol Human normal skin cell lines
THE MOST IMPORTANT RESULTS
• Combination of antioxidants
Page 19
Evolved as a part of a complex organization where each single component
Neither of them can do the work of the entire team
ANTIOXIDANTS
play a different role
Page 20
Human normal skin cell lines
Green tea • Combination
Resveratrol
γ-Oryzanol
Soy Isoflavones
Serini S. et al. Esperienze Dermatologiche, 2012
Human normal skin cell lines
Coenzyme Q10
Krill oil
• Combination
Lipoic acid Resveratrol
Grape seed oil α-Tocopherol
Na-Selenite
Fasano et al. BioMed Res International, 2014
• Combination Sulforaphan
Fernblock® XP
Human normal and neoplastic skin cell lines
Serini S. et al. (manuscript in preparation)
Page 21
ROS PRODUCTION (+/- H2O2)
LIPID PEROXIDATION (+/- PROOXIDANTS)
IL-6
MCP-1
CYTOKINE PRODUCTION (+/- TNF-α)
Coenzyme Q10
Krill oil
Combination
Lipoic acid
Resveratrol
Grape seed oil
α-Tocopherol
Na-Selenite
NF-κB ACTIVATION (+/- TNF-α)
IkBα PHOSPHORILATION
NF-κB(p65) EXPRESSION
Fasano et al. BioMed Res International, 2014
Page 22
Sulforaphan (SFN)
[1-Isothiocyanato-4-(methylsulfinyl) butane]
Found at high levels in vegetables of Brassicaceae (o Cruciferae) family,
especially in broccoli and cauliflowers
• Combination Sulforaphan
Fernblock® XP
Human normal and neoplastic skin cell lines
Serini S. et al. (manuscript in preparation)
Page 23
Fernblock® XP: Extract of Polypodium leucotomos (PL)
A tropical fern rich in phenolic compounds
Page 24
Previous studies on not-skin human and murine cell lines
SFN PL
• Antitumoral • Antioxidant • Anti-inflammatory
in vitro treatment
• Photoprotective • Antioxidant • Inti-inflammatory
Effects: Effects:
Page 25
• Cell growth • Cell migration • MMP Production
Human melanoma cells
Primary (WM115)
Metastatic (WM266-4)
Human Immortalized Keratinocytes
HaCaT
NCTC 2544
Treatment: • SFN 2.5 - 20 µM • PL 1 - 2 mg/ml
• ROS Production
Page 26
Both SFN and PL inhibit the of melanoma cell growth in dose- and time-dependent manners
WM115
Cel
ls (
x1
03)
0 24 48 72 (h)
Ctrl
SFN 5 μM
SFN 10 μM FB 1 mg/ml FB 2 mg/ml
SFN 20 μM
0
50000
100000
150000
200000
250000
300000
350000
0
50
100
150
200
250
300
350
Cel
ls (
x1
03) WM266-4
0 24 48 72 (h)
Ctrl
SFN 5 μM FB 1 mg/ml FB 2 mg/ml
SFN 20 μM
SFN 10 μM
0
50
100
150
200
250
300
350
Cell growth
Page 27
The combined treatment inhibits melanoma cell growth more efficiently than each single treatment
Cel
l g
row
th in
hib
itio
n
(% v
s co
ntr
ol)
Cell growth
Page 28
Anti-invasive effect Wound Healing assay
0
20
40
60
80
100
120
SFN 10 μM
ctrl
0 24 48 72 h 0
20
40
60
80
100
120
0 24 48 72 h
WM266-4
0
5
10
SFN(μM) WM115 c c c
c c
c
b, c
c
c
b
a
a
d d d
b
b, c
c, d
a
a
a
a
b
b
Cel
l fr
ee a
rea
(%
)
SFN powerfully inhibits human melanoma cell invasiveness in dose- and time-dependent manners
Page 29
PL powerfully inhibits cell invasive potential, more than SFN
0
20
40
60
80
100
120
ctrl
PL 2 mg/ml
0 24 48 72 h
WM115
0
20
40
60
80
100
120
0 24 48 72 h
WM266-4
0
1
2
PL (mg/ml) d d d
c c
c, d c, d c, d c, d c, d
b
a
c c c c c
c
b
a a
a
b, c
b, c
Cel
l fr
ee a
rea
(%
) Anti-invasive effect Wound Healing assay
Page 30
The combination powerfully inhibits cell invasiveness more than SFN e PL individually administered
Cel
l fr
ee a
rea (
%)
C
ell
free
are
a (
%)
Anti-invasive effect Wound Healing assay
Page 31
MMP evaluation: ELISA assay
The combined treatment inhibits MMP-2, MMP-3 and MMP-9 production
more than each single compound
MMP-3
MMP-2 MMP-9
Page 32
ROS evaluation: Cytofuorimetry
The combined teatment inhibits ROS production more than each single compound
RO
S p
rod
uct
ion
(% v
s co
ntr
ol)
RO
S p
rod
uct
ion
(% v
s co
ntr
ol)
RO
S p
rod
uct
ion
(% v
s co
ntr
ol)
RO
S p
rod
uct
ion
(% v
s co
ntr
ol)
Page 33
• SFN and PL
The use of a combination of SFN and PL may represent an important preventive strategy against the development of invasive melanoma
and the oxidative damage of keratinocytes
• SFN and PL
• Combination SFN + PL
Conclusions
cell growth
cell invasiveness
human melanoma cell lines
inhibit
inhibit intracellular ROS production
in human keratinocytes
than SFN or PL given separately
markedly more effective
Page 34
Experimental clinical trial on a significant number of patients monitored during the treatment
To verify the effectiveness of the combinations
Further step
SFN/PL
in vivo
Page 35
Thank you for your attention!
Acknowledgments
Prof. Simona Serini Dr. Roberta Guarino Dr. Nadia Mondella Dr. Elena Fasano Prof. Leonardo Celleno